GraniteShares 2x Long ISRG Daily ETF

SMX Security Matters

SpyGlass Pharma

GEN DIGITAL INC COM USD0.01 CVR (S/RS)

GraniteShares 2x Long MSTR Daily ETF

Daily Target 2X Long MSTR ETF

Defiance Daily Target 2X Long BITF ETF

Pulse Biosciences

T-REX 2X Long MSTR Daily Target ETF

Tradr 2X Long APLD Daily ETF

ISUL

Shares of Intuitive Surgical Inc. (ISRG) rose 2.48% to $488.15, marking a strong trading day as the S&P 500 and Dow Jones also increased. This rise ended an eight-day losing streak, although the stock remains 19.85% below its 52-week high of $609.08. In contrast, competitors Medtronic PLC and Stryker Corp. saw slight declines. Trading volume reached 2.5 million, surpassing the 50-day average of 1.8 million.

- Intuitive Surgical Inc. (ISRG) shares increased by 2.48% to $488.15, driven by a positive trading session in the stock market, with the S&P 500 and Dow Jones rising significantly.  
- The stock's rise ended an eight-day losing streak, but it remains 19.85% below its 52-week high of $609.08 reached on February 19th.  
- Trading volume was 2.5 million, exceeding the 50-day average of 1.8 million, while competitors like Medtronic PLC and Stryker Corp. saw slight declines.

Dow Jones

ALPS Medical Breakthrough

Pro UltrPro Dow30

SPDR S&P Health Equip

Direxion S&P Biotech Bear 3X

Medtronic

Invesco Biotechnology & Genome ETF

VG S&P 500

Stryker

iShares US Medical Devices

SPDR S&P Biotech

SPDR S&P 500

Intuitive Surgical Inc. Stock Outperforms Competitors On Strong Trading Day

ISRG

Intuitive Surgical Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission, identifying Iman Jeddi, SVP & GM of da Vinci Platforms, as the beneficial owner. The full filing is accessible via the SEC's EDGAR system. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial or legal advice.

Reuters

Intuitive Surgical

Intuitive Surgical Inc. Files Initial Statement of Beneficial Ownership for Iman Jeddi, SVP & GM da Vinci Platforms

Intuitive Surgical Inc. has filed an initial statement of beneficial ownership (Form 3) with the SEC, identifying Patricia L. Wadors as the beneficial owner in her role as an officer of the company. The filing is accessible through the SEC's EDGAR system. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.

Intuitive Surgical Inc. Files Initial Statement of Beneficial Ownership for Officer Patricia L. Wadors

Intuitive Surgical Inc. (ISRG) shares fell 3.59% to $478.88 on Tuesday, marking the sixth consecutive day of losses. The stock is now 21.38% below its 52-week high of $609.08. In contrast, competitors Medtronic PLC (MDT) rose 0.46%, while Stryker Corp. (SYK) dropped 1.99%. The overall market was down, with the S&P 500 Index falling 0.84% and the Dow Jones Industrial Average down 0.34%. Trading volume for ISRG was 3.8 million, surpassing its 50-day average of 1.8 million.

VanEck Biotech ETF

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

Intuitive Surgical Inc. Stock Underperforms Tuesday When Compared To Competitors

Intuitive Surgical (NASDAQ:ISRG) has delivered an average annual return of 18.58% over the past 15 years, outperforming the market by 6.98%. An investment of $1000 in ISRG stock 15 years ago would now be worth $12,876.47, reflecting the significant impact of compounded returns on investment growth. The company's current market capitalization stands at $169.36 billion.

benzinga_article

If You Invested $1000 In Intuitive Surgical Stock 15 Years Ago, You Would Have This Much Today

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical Inc., has reported the disposal of common shares of the company. The full filing is available through the provided link. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.

Intuitive Surgical EVP & Chief Medical Officer Myriam Curet Reports Disposal of Common Shares

Intuitive Surgical (NASDAQ:ISRG) has seen significant bullish options trading activity, with 37% of investors leaning bullish and 37% bearish. The predicted price range for ISRG is between $480.0 and $585.0. Current stock price is $505.48, down 0.41%. Analysts have a consensus target price of $644.0, with Barclays maintaining an Overweight rating and a target of $712. Options trading is riskier but offers higher profit potential, requiring traders to manage risks effectively.

Intuitive Surgical Options Trading: A Deep Dive into Market Sentiment

Strategic Advisors LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ: ISRG) by 63.3% in Q3, now holding 10,397 shares valued at $4.65 million. Other institutional investors also raised their positions, with Brighton Jones LLC increasing its holdings by 24.9%. Insider selling was noted, with EVP Henry L. Charlton selling 13,731 shares. Recent positive developments include FDA clearance for the da Vinci 5 system and strong quarterly results, while large insider sales have raised concerns about sentiment.

Market Beat

Strategic Advisors LLC Grows Stake in Intuitive Surgical, Inc. $ISRG

Gary S. Guthart, Director of Intuitive Surgical Inc., has reported the disposal of common shares of the company. The full filing is available through the provided link. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.

Intuitive Surgical Director Gary S. Guthart Reports Disposal of Common Shares

Bank of New York Mellon Corp reduced its stake in Intuitive Surgical, Inc. by 8.7% in Q3, now holding 4,123,290 shares valued at approximately $1.84 billion. Other institutional investors have also adjusted their positions, with Tobam increasing its holdings by 666.7%. Intuitive Surgical's stock opened at $525.04, with a market cap of $188.21 billion. Analysts remain optimistic, with TD Cowen initiating coverage with a $660 target, and HSBC raising its price target to $653, citing growth potential from the da Vinci 5 rollout and FDA clearance for cardiac procedures.

Bank of NY Mellon

Bank of New York Mellon Corp Trims Holdings in Intuitive Surgical, Inc. $ISRG

VSNT

MOLN

Top Wall Street analysts have initiated coverage on several companies with bullish ratings. Cantor Fitzgerald's Ramsey El-Assal rated Visa Inc (NYSE:V) as Overweight with a price target of $400, while TD Cowen's Mathew Blackman rated Intuitive Surgical Inc (NASDAQ:ISRG) as Buy with a target of $660. HC Wainwright's Robert Burns rated Molecular Partners AG (NASDAQ:MOLN) as Buy with a target of $13. Goldman Sachs' Michael Ng rated Versant Media Group Inc (NASDAQ:VSNT) as Neutral with a target of $34, and El-Assal also rated Mastercard Inc (NYSE:MA) as Overweight with a target of $650.

- Wall Street analysts have made changes to their ratings on several companies, including new coverage initiatives.  
- Cantor Fitzgerald's Ramsey El-Assal has given Visa an Overweight rating with a $400 price target, while Intuitive Surgical received a Buy rating from TD Cowen, targeting $660.  
- Other notable ratings include Buy for Molecular Partners at $13, and a Neutral rating for Versant Media at $34 from Goldman Sachs.

Mastercard

Versant Media

Visa

Molecular Partners

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Intuitive Surgical (ISRG) has received a Buy rating from TD Cowen, with a target price of $660. The rating is based on the strong product cycle and growth prospects tied to the Da Vinci 5 platform rollout, which is expected to expand the installed base and accelerate system upgrades. TD Cowen's analysis indicates that Intuitive Surgical will maintain a dominant share in robotic acquisitions, driven by factors such as broader access in acute-care settings and international expansion. The firm projects revenue and procedure volume growth exceeding consensus expectations through 2026-2028.

- Intuitive Surgical (ISRG) received a new "buy" rating from TD Cowen analysts, motivated by factors such as strong product cycles and growth prospects.  
- The company anticipates that the global promotion of the Da Vinci 5 platform will not only expand the installed base but also increase system upgrades, unlocking additional surgical volume.  
- TD Cowen expects revenues, surgical volume, and system installations to exceed market consensus from 2026 to 2028, positioning Intuitive Surgical as a core medical technology holding with attractive upside potential.

Tip Ranks

Intuitive Surgical: Da Vinci 5 Rollout and Secular Procedure Growth Underpin TD Cowen Buy Rating and $660 Target

Intuitive Surgical shares climbed in late trading Thursday after the company reported fourth-quarter profit that...

Intuitive Surgical shares rise on profit beat

FDA has granted 510(k) clearance to expand the da Vinci surgical system's indications to include certain cardiac procedures. This approval allows for a broader range of heart surgeries, highlighting the system's safety and efficacy. The update opens new opportunities in minimally invasive surgery, benefiting more patients and showcasing the growing acceptance of robotic-assisted surgery in the medical community.

Unusual Whales

FDA clears da Vinci 5 for cardiac procedures, expanding indications with 510(k) clearance.

China Merchants Securities has initiated coverage on Intuitive Surgical, giving it an "Overweight" rating with a target price of $613. The report points out that Intuitive Surgical holds an absolute leadership position in the surgical robotics field, with expected continuous growth in surgical volume in the future. The fifth-generation "Da Vinci 5" system has improved equipment utilization, with surgical volume expected to increase by 13% to 15% by 2026. The company's revenue and net profit are expected to maintain stable growth from 2026 to 2028, increasing by 16%, 15%, and 15%, respectively

AASTOCKS

CITIC Securities initiates coverage on Intuitive Surgical with a "Buy" rating and a target price of $613, the absolute leader in the surgical robotics field

GraniteShares 2x Long ISRG Daily ETF(ISUL.US)

Intuitive Surgical Inc. Stock Outperforms Competitors On Strong Trading Day

Intuitive Surgical Inc. Files Initial Statement of Beneficial Ownership for Iman Jeddi, SVP & GM da Vinci Platforms

Intuitive Surgical Inc. Files Initial Statement of Beneficial Ownership for Officer Patricia L. Wadors

Intuitive Surgical Inc. Stock Underperforms Tuesday When Compared To Competitors

If You Invested $1000 In Intuitive Surgical Stock 15 Years Ago, You Would Have This Much Today